Organogenesis Inc. · Canton, MA United States
| 150 Dan Rd. | Phone: 781-575-0775 |
| Canton, MA | Fax: 781-575-0440 |
| 02021 | |
| United States | 
Map This Company |
Organogenesis Inc. Rankings
More Companies in These Related Industries: Biologics MfgCompany Description
Organogenesis has the skinny on replacement tissue. Flagship product Apligraf is a human skin substitute approved to treat diabetic foot ulcers and venous leg ulcers caused by poor circulation. Rejection-resistant Apligraf is bio-engineered using living skin cells and has been used to treat chronic open wounds in some 250,000 patients; the company is developing a next-generation version of the material (using its VCT technology) using all human components. In addition to Apligraf, Organogenesis offers a line of biomaterials used in a range of surgical procedures to seal or reconstruct soft tissue, and it also develops regenerative technologies in the area of cosmetic skin rejuvenation.
Organogenesis Inc. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | PrivateHeadquarters |
|---|---|
| Fiscal Year-End | December |
| Employees | 182 |
Executives
28 executives listed for Organogenesis Inc.'s Canton, MA location.